Article info

Download PDFPDF
Extended report
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study

Authors

  1. Correspondence to Dr Jakub Závada, Institute of Rheumatology, Na Slupi 4, Praha 2, 12850, Czech Republic; zavada{at}revma.cz
View Full Text

Citation

Závada J, Uher M, Sisol K, et al
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study

Publication history

  • Received January 7, 2014
  • Revised August 4, 2014
  • Accepted August 10, 2014
  • First published August 27, 2014.
Online issue publication 
December 11, 2015

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.